FIELD: chemistry.
SUBSTANCE: group of inventions relates to organic synthesis, specifically to 2,6-bis(aminovinyl)-4-methylene-1,4-dihydropyridine derivatives of formula I and a method for production thereof. In formula I R1 is Bn, Ph, n-Bu, Oct, CH2CH2NMe2, CH2CH(OMe)2, CH2CH2OH, 2-MeOC6H4, 4-MeOC6H4; R2 and R3 are Me; A is dicyanomethylidene, 1,3-dioxo-1,3-dihydro-2H-inden-2-ylidene, 1-(dicyanomethylene)-3-oxo-1,3-dihydro-2H-inden-2-ylidene, 1,3-dimethyl-2,4,6-trioxotetrahydropyrimidine-5(2H)-ylidene, 1,3-diethyl-4,6-dioxo-2-thioxotetrahydropyrimidine-5(2H)-ylidene.
EFFECT: synthesis of compounds of formula I based on 1,4-dihydropyridines, having luminescent properties, using commercially available reagents without using column chromatography methods for purifying desired products.
2 cl, 2 dwg, 17 ex
Title | Year | Author | Number |
---|---|---|---|
POLY[(2,7-BIS(1',4'-PHENYLENE)DIBENZO[A,C]PHENAZINE-4',4'-DIYL)1,4-PHENYLENEDIMETHANIMINE-N,N'-DIYL] | 2023 |
|
RU2817296C1 |
SUBSTITUTED BENZENE COMPOUNDS | 2012 |
|
RU2629118C2 |
PROTEIN KINASE INHIBITORS FOR ENHANCING LIVER REGENERATION OR REDUCING OR PREVENTING HEPATOCYTE DEATH | 2019 |
|
RU2822216C2 |
METHOD FOR OBTAINING DISPYROINDOLINONES BASED ON 5-INDOLIDENE-2-THIOHIDANTOINES | 2020 |
|
RU2756463C1 |
PHENOTHIAZINE-CONTAINING 1,2,3,4-TETRAHYDROPYRIDO[4,3-b]INDOLE DERIVATIVES AS AGENT FOR REDUCING UNCONTROLLED PROTEIN AGGREGATION IN NERVOUS SYSTEM, METHODS FOR PRODUCTION THEREOF, PHARMACOLOGICAL AGENT BASED THEREON AND METHOD OF REDUCING UNCONTROLLED PROTEIN AGGREGATION IN NERVOUS SYSTEM | 2013 |
|
RU2529899C1 |
TREATMENT METHOD | 2012 |
|
RU2621148C2 |
NOVEL FUSED PYRIMIDINE COMPOUND OR SALT THEREOF | 2014 |
|
RU2666349C2 |
PYRAZINE COMPOUNDS AND THEIR USE | 2019 |
|
RU2809631C2 |
PYRIDINONE AND PYRIDAZINONE DERIVATIVES | 2012 |
|
RU2632915C2 |
6-TRIFLUORO(TRICHLORO)METHYL-SUBSTITUTED SPIRO[CHROMENO[3,4-a]PYRROLIZIDINE-11,3'-INDOLINE]-2'-ONES SHOWING ANTITUMOR ACTIVITY, AND THEIR PRODUCTION METHOD | 2020 |
|
RU2775605C2 |
Authors
Dates
2024-08-07—Published
2023-12-13—Filed